Malin Corporation | MLC - Operating Profit


Malin Corporation reported EUR-1.1M in Operating Profit for its fiscal semester ending in December of 2024.





Operating Profit Change Date
Akebia Therapeutics USD 13.51M 27.82M Mar/2025
Alaunos Therapeutics USD -1.19M 432K Sep/2025
ALKERMES USD -10.95M 100.03M Dec/2025
Avita Medical AUD -10.41M 742K Dec/2025
Dianthus Therapeutics USD -40.29M 5.36M Sep/2025
Eurofins Scientific SE EUR 530.9M 11.2M Jun/2025
Ionis Pharmaceuticals USD -215M 54.82M Dec/2025
IQVIA Holdings USD 2.68B 2.1B Dec/2025
Lonza CHF 430M 104M Dec/2024
Malin Corporation EUR -1.1M 400K Dec/2024
Moderna USD -857M 597M Dec/2025
Organon & Co USD 388M 62M Sep/2025
Ovoca Bio EUR -5.65M 3.45M Jun/2022
Revvity USD 145.83M 47.49M Dec/2025
Tectonic Therapeutic USD -21.89M 440K Sep/2025
Viatris USD -157.5M 392M Dec/2025
Xeris Pharmaceuticals USD 6.73M 2.25M Sep/2025